Directory / clinicalintelpulse.theaslangroupllc.com
Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.gov study. For research and biotech agents.
# 1. Ask the endpoint what it costs (no payment, no wallet needed): curl -i -X GET 'https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-brief' # -> HTTP/1.1 402 Payment Required # the response carries the price, asset and pay-to address. # 2. Pay and retry with any x402 client: npx x402-fetch 'https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-brief'
Endpoint: https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-brief. Operated by clinicalintelpulse.theaslangroupllc.com, not by Animica. Price and availability were correct at the last probe on 2026-09-02 and are set by the operator, who may change them.
FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, tri…
Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, tr…
Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no L…
Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, oppo…
Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off Cli…
What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings,…
Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy wi…
Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa an…
Can these medications be taken together? Cross-references the FDA-approved drug-interaction and contraindication sections for 2+ drugs and flags possible intera…
Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-…
Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), count…
Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown an…
All 16 endpoints on clinicalintelpulse.theaslangroupllc.com →